Regeneron reports fourth quarter and full year 2022 financial and operating results

Tarrytown, n.y., feb. 03, 2023 (globe newswire) -- regeneron pharmaceuticals, inc. (nasdaq: regn) today announced financial results for the fourth quarter and full year 2022 and provided a business update.

REGN Ratings Summary

REGN Quant Ranking